• Developed as a condition-specific quality of life measure for individuals with SCI who have urinary disorders that could be used in international multi-centre trials.
  • Developed by a multi-disciplinary group of experts and the questions were derived based on the literature and individuals with SCI.
  • Contains 4 domains:

1) Limitations / Inconvenience (items 1-9)
2) Constraints / Restrictions (items 10-17)
3) Fears (items 18-25)
4) Feelings / Impact on Daily Life (items 26-30)

Clinical Considerations

The Qualiveen was developed specifically for individuals with SCI and was developed with input from individuals with SCI.

ICF Domain

Quality of Life

Administration

  • Can be administered by interviewer or be self-administered.
  • The questionnaire is based on a 5 point Likert scale.
  • Administration time is under 30 minutes.

Number of Items

30

Equipment

 None

Scoring

  • Each domain score is calculated as an average of the scores for the domain items.
  • An overall (averaged) score can also be calculated.

Languages

English, French, Dutch, German, Turkish, Persian, Greek, Polish, and Italian.

Training Required

Does not require advanced training.

Availability

Can be purchased here.

Information for the Qualiveen-30 can be found here.

Measurement Property Summary

# of studies reporting psychometric properties: 2

Interpretability

  • Each of the four scales are scored from 0 – 100, where lower scores indicate a better quality of life (i.e. no limitations, fears, constraints, or negative feelings) and higher scores indicate a poorer quality of life.
  • Data is only provided from one study, so no normative data exists for the SCI population.
  • Reference scores for different gender, age and type of lesion are available from the Qualiveen manual on 400 individuals with SCI (see the Interpretability section of the Study Details page).

MCID: not established in SCI
SEM: not established in SCI
MDC: not established in SCI

Reliability

  • Internal consistency is High for the total Qualiveen scale (Cronbach’s a = 0.80) as well as for all the Qualiveen subscales (Cronbach’s a = 0.81-0.85).
  • Test-retest reliability is High for the 4 Qualiveen subscales (ICC = 0.85-0.92).

(Costa et al. 2001)

Validity

  • As expected, correlations of Qualiveen subscales to overall Qualiveen are positive and:
    • Moderate to High for Qualiveen-Limitations (Pearson’s r = 0.52-0.65)
    • Moderate to High for Qualiveen-Constraints (Pearson’s r = 0.43-0.66)
    • Moderate to High for Qualiveen-Fears (Pearson’s r = 0.39-0.60)
    • Moderate to High for Qualiveen-Feelings (Pearson’s r = 0.50-0.77).
  • Correlations between items in each domain and non-corresponding domains are Low to High for Qualiveen-Limitations (Pearson’s r = 0.29-0.64), and Low to Moderate for Qualiveen-Constraints (Pearson’s r = 0.18-0.59), Qualiveen-Fears (Pearson’s r = 0.12-0.40) and Qualiveen-Feelings (Pearson’s r = 0.28-0.57).

(Costa et al. 2001)

Responsiveness

No values were reported for the responsiveness of the Qualiveen scale for the SCI population at this time.

Floor/Ceiling Effect

Floor and ceiling effects were minimal for the Qualiveen scale.

(Costa et al. 2001; Nikfallah et al., 2015)

Reviewers

Dr. Bill Miller, Dr. Carlos Cano-Herrera

Date Last Updated

31 December 2024

Cintra LKL, de Bessa J Júnior, Kawahara VI, Ferreira TPA, Srougi M, Battistella LR, de Souza DR, Bruschini H, Gomes CM. Cross-cultural adaptation and validation of the neurogenic bladder symptom score questionnaire for Brazilian Portuguese. Int Braz J Urol. 2019 May-Jun;45(3):605-614. https://pubmed.ncbi.nlm.nih.gov/31063278/

Costa P, Perrouin-Verbe B, Colvez A, Didier J, Marquis P, Marrel A, Amarenco G, Espirac B, Leriche A. Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen. Eur Urol 2001;39:107-113.
http://www.ncbi.nlm.nih.gov/pubmed/11173948

D’Ancona, C.A.L., Tamanini, J.T., Botega, N. et al. Quality of life of neurogenic patients: translation and validation of the Portuguese version of Qualiveen. Int Urol Nephrol 41, 29–33 (2009). https://link.springer.com/article/10.1007/s11255-008-9402-3

Khadour YA, Ebrahem B, Khadour FA. Arabic version of the SF-Qualiveen: cross-cultural adaptation, translation, and validation of urinary disorder-specific instruments in patients with spinal cord injury. J Orthop Surg Res. 2024 Jan 12;19(1):56. https://pubmed.ncbi.nlm.nih.gov/38217026/

Khadour YA, Ebrahem BM, Khadour FA. Cross-cultural adaptation, translation, and validation of the Arabic version of the short form of Neurogenic Bladder Symptoms Score. Neurourol Urodyn. 2023 Jun;42(5):1152-1161. https://pubmed.ncbi.nlm.nih.gov/37086397/ 

Khadour YA, Zheng M, Khadour FA. The validity and reliability of the Arabic version of the short form of neurogenic bladder symptoms score in patients with spinal cord injury. J Orthop Surg Res. 2023 Jun 27;18(1):464. https://pubmed.ncbi.nlm.nih.gov/37370161/

Konstantinidis C, Tzitzika M, Daoultzis KC, Samarinas M, Giannitsas K, Athanasopoulos A. Translation and cultural adaptation of SF Qualiveen questionnaire in Greek. Eur J Phys Rehabil Med. 2021 Aug;57(4):639-644. https://pubmed.ncbi.nlm.nih.gov/33179476/

Krebs J, Wöllner J, Widmer A, Pannek J. An instrument for assessing quality of life in persons with neurogenic lower urinary tract dysfunction: validation of the German short-form Qualiveen questionnaire. Spinal Cord. 2022 Apr;60(4):306-311. https://pubmed.ncbi.nlm.nih.gov/34556820/

Moreno-Palacios J, Castro-Nuñez P, Padilla-Fernández B, Beltran-Martinez L, Katz-Nestor O, Braschi E, Garrido G. Cross-cultural adaptation and validation of the neurogenic bladder symptom score for Spanish speakers. Neurourol Urodyn. 2021 Nov;40(8):1939-1944. https://pubmed.ncbi.nlm.nih.gov/34396560/

Nikfallah A, Rezaali S, Mohammadi N, et al. Translation, Cultural Adaptation and Validation of the Qualiveen-30 Questionnaire in Persian for Patients with Spinal Cord Injury and Multiple Sclerosis. Low Urin Tract Symptoms. 2015;7(1):42-9.
http://www.ncbi.nlm.nih.gov/pubmed/26663651

Przydacz M, Kornelak P, Dudek P, Golabek T, Chlosta P. The urinary disorder-specific quality of life in patients after spinal cord injury: Polish translation, adaptation and validation of the Qualiveen and SF-Qualiveen. Spinal Cord. 2021 Feb;59(2):105-111. https://pubmed.ncbi.nlm.nih.gov/32541884/

Reuvers SHM, Korfage IJ, Scheepe JR, ‘t Hoen LA, Sluis TAR, Blok BFM. The validation of the Dutch SF-Qualiveen, a questionnaire on urinary-specific quality of life, in spinal cord injury patients. BMC Urol. 2017 Sep 19;17(1):88. https://pubmed.ncbi.nlm.nih.gov/28927392/